Julie Wierzbicki/LinkedIn
Jun 6, 2025, 05:24
Julie Wierzbicki: ASCO 2025 Highlights – Liquid Biopsy and Advances in Small Cell Lung Cancer
Julie Wierzbicki, Journalist and editor at Pharmaceutiques, shared a post on LinkedIn:
“Today on Pharmaceutiques.com, we take a look back at the 2025 edition of the American Society of Clinical Oncology (ASCO) Congress, which has just ended in Chicago, with a focus on the new perspectives of liquid biopsy to detect a treatment-resistant mutation before any clinical sign of disease progression and adapt therapy accordingly in metastatic HR+/HER2- breast cancer. There are also two encouraging studies in small cell lung cancer, which has so far benefited very little from significant therapeutic advances.”
-
Challenging the Status Quo in Colorectal Cancer 2024
December 6-8, 2024
-
ESMO 2024 Congress
September 13-17, 2024
-
ASCO Annual Meeting
May 30 - June 4, 2024
-
Yvonne Award 2024
May 31, 2024
-
OncoThon 2024, Online
Feb. 15, 2024
-
Global Summit on War & Cancer 2023, Online
Dec. 14-16, 2023
Jun 7, 2025, 14:53
Jun 7, 2025, 14:10